Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Teva
Dow
Citi
Accenture
Argus Health
Covington
Merck
Farmers Insurance

Generated: December 16, 2018

DrugPatentWatch Database Preview

Drug Price Trends for FLUOXETINE

« Back to Dashboard

Drug Price Trends for FLUOXETINE

Average Pharmacy Cost for FLUOXETINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Glossary
Drug Name NDC Price/Unit ($) Unit Date
FLUOXETINE HCL 40 MG CAPSULE 65862-0194-01 0.09258 EA 2018-12-12
FLUOXETINE HCL 60 MG TABLET 75834-0148-30 5.91409 EA 2018-11-21
FLUOXETINE HCL 10 MG CAPSULE 68645-0131-54 0.03182 EA 2018-11-21
FLUOXETINE HCL 20 MG CAPSULE 68645-0130-54 0.03071 EA 2018-11-21
FLUOXETINE HCL 20 MG CAPSULE 68084-0605-11 0.03071 EA 2018-11-21
FLUOXETINE HCL 20 MG CAPSULE 68084-0605-01 0.03071 EA 2018-11-21
FLUOXETINE HCL 40 MG CAPSULE 68084-0101-11 0.09258 EA 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for FLUOXETINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Glossary
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
FLUOXETINE 20MG CAP UNIT DOSE 10X10 Major Pharmaceuticals 00904-5785-61 100 4.64 0.04640 EA 2018-12-01 - 2023-11-30 FSS
FLUOXERINE 10MG CAP UNIT DOSE 10X10 Major Pharmaceuticals 00904-5784-61 100 4.79 0.04790 EA 2018-12-01 - 2023-11-30 FSS
SARAFEM 10MG CAP 4X7 Allergan USA, Inc 00430-0210-14 28UD 264.95 9.46250 EA 2018-09-30 - 2023-09-29 Big4
SARAFEM 10MG CAP 4X7 Allergan USA, Inc 00430-0210-14 28UD 549.03 19.60821 EA 2018-09-30 - 2023-09-29 FSS
SARAFEM 20MG CAP 4X7 Allergan USA, Inc 00430-0220-14 28UD 264.95 9.46250 EA 2018-09-30 - 2023-09-29 Big4
SARAFEM 20MG CAP 4X7 Allergan USA, Inc 00430-0220-14 28UD 549.03 19.60821 EA 2018-09-30 - 2023-09-29 FSS
PROZAC 10MG CAP Eli Lilly & Company 00777-3104-02 100 725.93 7.25930 EA 2018-08-01 - 2023-07-31 Big4
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Mallinckrodt
Cantor Fitzgerald
Daiichi Sankyo
Cerilliant
Deloitte
Cipla
Accenture
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: